Efficacy and Reported Outcomes With JAK Inhibitors in Atopic

Experts in dermatology discuss efficacy and patient-reported outcomes of topical and systemic JAK inhibitors and dosing guidelines in atopic dermatitis.

Related Keywords

United States , , Linda Stein Gold , Stein Gold , Atopic Dermatitis , Sad , Jak Inhibitors , Ruxolitinib , Topical And Systemic Jak Inhibitors , Dosing Guidelines In Ad ,